Brian Downer1, Benjamin N Vickers2, Soham Al Snih3, Mukaila Raji4, Kyriakos S Markides2. 1. Sealy Center on Aging, University of Texas Medical Branch, Galveston, Texas. 2. Department of Preventive Medicine and Community Health, University of Texas Medical Branch, Galveston, Texas. 3. Department of Rehabilitation Sciences, University of Texas Medical Branch, Galveston, Texas. 4. Division of Geriatrics, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas.
Abstract
OBJECTIVES: To assess the relationship between comorbid depression, diabetes mellitus (DM), and cognitive decline in Mexican Americans aged 65 and older. DESIGN: Retrospective cohort study with longitudinal analysis. SETTING: Texas, New Mexico, Colorado, Arizona, and California. PARTICIPANTS: Hispanic Established Populations for the Epidemiologic Study of the Elderly. MEASUREMENTS: Cognition was assessed using the Mini-Mental State Examination (MMSE). Depression was defined as a score of 16 or greater on the Center for Epidemiologic Studies Depression Scale. DM was defined as according to self-reported history or taking insulin or oral hypoglycemic medication. RESULTS: Participants with depression and DM declined an average of 6.5 points on the MMSE; depression only, 4.4 points; DM only, 7.8 points; and neither condition, 4.2 points across the six examination waves. Participants with DM declined an average of 0.18 more points on the MMSE per year (P=.001) than those with neither DM nor depression, and those with comorbid DM and depression declined 0.25 more points per year (P=.002). Depression was associated with significantly greater cognitive decline (β^=-0.11, P=.05) after excluding participants with baseline cognitive impairment (MMSE score≤17). Participants with DM were 1.08 (95% CI=1.03-1.12) times as likely as those with neither DM nor depression, and those with comorbid DM and depression were 1.08 (95% CI=1.01-1.15) times as likely as those with neither DM nor depression to develop severe cognitive impairment per year. CONCLUSION: DM and comorbid depression and DM are risk factors for cognitive decline in older Mexican Americans. Interventions that reduce the prevalence of depression and DM in Mexican Americans may decrease the number of older adults who experience cognitive decline.
OBJECTIVES: To assess the relationship between comorbid depression, diabetes mellitus (DM), and cognitive decline in Mexican Americans aged 65 and older. DESIGN: Retrospective cohort study with longitudinal analysis. SETTING: Texas, New Mexico, Colorado, Arizona, and California. PARTICIPANTS: Hispanic Established Populations for the Epidemiologic Study of the Elderly. MEASUREMENTS: Cognition was assessed using the Mini-Mental State Examination (MMSE). Depression was defined as a score of 16 or greater on the Center for Epidemiologic Studies Depression Scale. DM was defined as according to self-reported history or taking insulin or oral hypoglycemic medication. RESULTS:Participants with depression and DM declined an average of 6.5 points on the MMSE; depression only, 4.4 points; DM only, 7.8 points; and neither condition, 4.2 points across the six examination waves. Participants with DM declined an average of 0.18 more points on the MMSE per year (P=.001) than those with neither DM nor depression, and those with comorbid DM and depression declined 0.25 more points per year (P=.002). Depression was associated with significantly greater cognitive decline (β^=-0.11, P=.05) after excluding participants with baseline cognitive impairment (MMSE score≤17). Participants with DM were 1.08 (95% CI=1.03-1.12) times as likely as those with neither DM nor depression, and those with comorbid DM and depression were 1.08 (95% CI=1.01-1.15) times as likely as those with neither DM nor depression to develop severe cognitive impairment per year. CONCLUSION:DM and comorbid depression and DM are risk factors for cognitive decline in older Mexican Americans. Interventions that reduce the prevalence of depression and DM in Mexican Americans may decrease the number of older adults who experience cognitive decline.
Authors: Wayne Katon; Courtney R Lyles; Melissa M Parker; Andrew J Karter; Elbert S Huang; Rachel A Whitmer Journal: Arch Gen Psychiatry Date: 2011-12-05
Authors: Kathryn P Riley; Gregory A Jicha; Daron Davis; Erin L Abner; Gregory E Cooper; Nancy Stiles; Charles D Smith; Richard J Kryscio; Peter T Nelson; Linda J Van Eldik; Frederick A Schmitt Journal: J Alzheimers Dis Date: 2011 Impact factor: 4.472
Authors: David C Steffens; Gwenith G Fisher; Kenneth M Langa; Guy G Potter; Brenda L Plassman Journal: Int Psychogeriatr Date: 2009-06-12 Impact factor: 3.878
Authors: Michael A Rapp; Michal Schnaider-Beeri; Michael Wysocki; Elizabeth Guerrero-Berroa; Hillel T Grossman; Andreas Heinz; Vahram Haroutunian Journal: Am J Geriatr Psychiatry Date: 2011-04 Impact factor: 4.105
Authors: Tatiana Perrino; Craig A Mason; Scott C Brown; Arnold Spokane; José Szapocznik Journal: J Gerontol B Psychol Sci Soc Sci Date: 2008-09 Impact factor: 4.077
Authors: Wayne J Katon; Elizabeth H B Lin; Lisa H Williams; Paul Ciechanowski; Susan R Heckbert; Evette Ludman; Carolyn Rutter; Paul K Crane; Malia Oliver; Michael Von Korff Journal: J Gen Intern Med Date: 2010-01-28 Impact factor: 5.128
Authors: Elizabeth Guerrero-Berroa; Ramit Ravona-Springer; James Schmeidler; Anthony Heymann; Laili Soleimani; Mary Sano; Derek Leroith; Rachel Preiss; Ruth Zukran; Jeremy M Silverman; Michal Schnaider Beeri Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Mônica M Teixeira; Valéria M A Passos; Sandhi M Barreto; Maria I Schmidt; Bruce B Duncan; Alline M R Beleigoli; Maria J M Fonseca; Pedro G Vidigal; Larissa F Araújo; Maria de Fátima H S Diniz Journal: Sci Rep Date: 2020-01-31 Impact factor: 4.379